Carto 3三维心脏标测系统

Search documents
获批上市!首款开放三维介电标测系统
思宇MedTech· 2025-05-21 08:16
Core Viewpoint - The article highlights the significant advancements in cardiac electrophysiology technology, particularly focusing on the launch of the StarTrek® system by Jianhu Medical, which represents a breakthrough in domestic electrophysiology solutions [2][8]. Group 1: Industry Overview - Atrial fibrillation (AF) is the most common arrhythmia, affecting nearly 20 million patients in China, yet the number of surgical procedures remains low compared to coronary interventions [7]. - The market for three-dimensional mapping technology has evolved significantly, with major players like Johnson & Johnson and Abbott dominating the field, creating a monopolistic environment [7][8]. Group 2: Product Introduction - The StarTrek® system is the first domestic open three-dimensional dielectric imaging mapping system, integrating imaging, mapping, navigation, and damage assessment [8][10]. - The system offers high precision with a positioning accuracy of 0.4 mm and stability of 0.1 mm, significantly reducing the time required for mapping compared to traditional methods [14]. Group 3: Clinical Performance - In clinical trials, the StarTrek® system demonstrated lower pain responses and no adverse events during procedures for drug-resistant paroxysmal atrial fibrillation [10]. - The system allows for real-time observation of myocardial conditions and damage assessment during ablation, enhancing the success rate of procedures [14]. Group 4: Company Background - Jianhu Medical was founded in 2021, led by a team with extensive experience from major medical device companies, focusing on integrated solutions for cardiac electrophysiology [31]. - The company has developed both three-dimensional dielectric mapping technology and nanosecond pulsed electric field ablation technology, positioning itself uniquely in the market [31]. Group 5: Competitive Landscape - Other notable players in the three-dimensional mapping system market include Boston Scientific, Medtronic, and Abbott, each with their own innovative products and technologies [16][18][20][23]. - The competitive landscape is characterized by continuous technological advancements and regulatory approvals, with several systems recently gaining market entry [22][25][27][29].